HOLX – hologic, inc. (US:NASDAQ)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day HOLX SPY QQQ SPX
Date
Time
Symbol
Company Name
Action
%Chg
1/29/2026
04:02 pm
holx
hologic, inc.
MISS
-0.1%
11/3/2025
04:01 pm
holx
hologic, inc.
BEAT
0.1%
7/30/2025
04:01 pm
holx
hologic, inc.
BEAT
2.8%
5/1/2025
04:01 pm
holx
hologic, inc.
BEAT
-5.4%
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions?
The answers are right here.
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Top News Gainers
3/19 CDC, public labs have conducted 37,824 COVID-19 tests [MarketWatch] 6.5%
3/18 CDC, public health labs have conducted at least 31,000 tests [MarketWatch] 5.8%
4/23 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.1%
4/2 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Needham & Company LLC from $62.00 to $52.00. They now have a "buy" rating on the stock. 4.8%
4/8 Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair. 4.7%
11/20 Clayton, Dubilier & Rice to Acquire Market-Leading Medical Aesthetics Technology Company 4.3%
3/9 Form 4 HOLOGIC INC For: Mar 05 Filed by: HANTSON LUDWIG 4.0%
4/7 Form 8-K HOLOGIC INC For: Apr 07 2.9%
3/26 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Barclays PLC from $51.00 to $43.00. They now have an "equal weight" rating on the stock. 2.8%
1/31 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at TheStreet from a "c" rating to a "b+" rating. 2.7%
Top News Decliners
3/17 Form 8-K HOLOGIC INC For: Mar 16 -11.4%
3/11 Form 4 HOLOGIC INC For: Mar 09 Filed by: CRAWFORD SALLY -9.9%
4/30 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Needham & Company LLC from $52.00 to $60.00. They now have a "buy" rating on the stock. -8.1%
3/20 CDC, public health labs performed at least 44,000 COVID-19 tests [MarketWatch] -5.9%
11/7 Hologic, Inc. (HOLX) CEO Steve MacMillan on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -5.3%
10/1 Hologic CEO Steve MacMillan to Ring Nasdaq Opening Bell on October 2 -4.5%
3/10 Form 8-K HOLOGIC INC For: Mar 05 -4.5%
8/14 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus to $62.00. They now have a "buy" rating on the stock. -4.4%
3/5 German Lab Demonstrates Feasibility to Detect SARS-Coronavirus-2 (SARS-CoV-2) Using Hologic’s Panther Fusion® System -4.3%
3/21 CDC, public health labs have tested at least 54,205 Americans for coronavirus [MarketWatch] -3.7%

Don’t Miss Out On The Next BIG Stock Move

Thanks for submitting the form.
HOLX – hologic, inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
HOLX
SPY
QQQ
SPX
HOLX – hologic, inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
HOLX SPY QQQ SPX
Stock Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Stock Stats
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
News
2/4
08:15 am
holx
Low
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio
1/30
07:12 pm
holx
Low
HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash [Yahoo! Finance]
1/30
06:06 am
holx
Low
Hologic (NASDAQ:HOLX) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
1/29
04:02 pm
holx
Low
Hologic Announces Financial Results for First Quarter of Fiscal 2026
1/23
04:36 pm
holx
Low
Analysts consider potential Qiagen deal amid reported strategic review [Yahoo! Finance]
1/19
06:16 pm
holx
Low
Hologic, Inc. (HOLX): A Bear Case Theory [Yahoo! Finance]
1/19
10:10 am
holx
Low
Pop-Up Clinics Increasing Access to Cervical Cancer Screenings this Cervical Health Awareness Month [Yahoo! Finance]
1/15
07:00 pm
holx
Low
Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026
1/13
09:00 am
holx
Low
Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening
1/29/2026
04:02 pm
holx
-0.1%
MISS
11/3/2025
04:01 pm
holx
0.1%
BEAT
7/30/2025
04:01 pm
holx
2.8%
BEAT
5/1/2025
04:01 pm
holx
-5.4%
BEAT
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
1/12
10:49 am
Downgrades
Buy
Hold
Argus Research
Low
0.0%
1/12
09:18 am
Downgrades
Buy
Hold
Argus
Low
0.1%
1/12
09:18 am
Downgrades
Buy
Hold
Argus
Low
0.1%
1/12
08:03 am
Downgrades
BUY
HOLD
ARGUS
Low
0.6%
1/12
08:03 am
Downgrades
BUY
HOLD
ARGUS
Low
0.6%
1/12
08:02 am
Downgrades
ARGUS
Low
0.6%
1/12
08:02 am
Downgrades
ARGUS
Low
0.6%
1/5
01:00 pm
Downgrades
Outperform
In-Line
Evercore ISI Group
Low
-0.1%
1/5
09:00 am
Downgrades
Outperform
Inline
Evercore ISI
Low
0.3%
2/12
04:11 pm
holx
Low
Form 4 HOLOGIC INC For: Feb 10 Filed by: Horvath Mark W.
2/6
08:00 am
holx
Low
Form 8-K HOLOGIC INC For: Feb 05
2/3
05:11 pm
holx
Low
Form 4/A HOLOGIC INC For: Jan 30 Filed by: De Walt Diana
2/3
04:19 pm
holx
Low
Form 4 HOLOGIC INC For: Jan 30 Filed by: De Walt Diana
1/29
04:09 pm
holx
Low
Form 10-Q HOLOGIC INC For: Dec 27
1/29
04:04 pm
holx
Low
Form DEFA14A HOLOGIC INC
1/29
04:03 pm
holx
Low
Form 8-K HOLOGIC INC For: Jan 29
1/26
04:36 pm
holx
Low
Form DEFA14A HOLOGIC INC
1/26
04:31 pm
holx
Low
Form 8-K HOLOGIC INC For: Jan 26
Show more
Top News Gainers
3/19 CDC, public labs have conducted 37,824 COVID-19 tests [MarketWatch] 6.5%
3/18 CDC, public health labs have conducted at least 31,000 tests [MarketWatch] 5.8%
4/23 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.1%
4/2 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Needham & Company LLC from $62.00 to $52.00. They now have a "buy" rating on the stock. 4.8%
4/8 Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair. 4.7%
11/20 Clayton, Dubilier & Rice to Acquire Market-Leading Medical Aesthetics Technology Company 4.3%
3/9 Form 4 HOLOGIC INC For: Mar 05 Filed by: HANTSON LUDWIG 4.0%
4/7 Form 8-K HOLOGIC INC For: Apr 07 2.9%
3/26 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Barclays PLC from $51.00 to $43.00. They now have an "equal weight" rating on the stock. 2.8%
1/31 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at TheStreet from a "c" rating to a "b+" rating. 2.7%
Top News Decliners
3/17 Form 8-K HOLOGIC INC For: Mar 16 -11.4%
3/11 Form 4 HOLOGIC INC For: Mar 09 Filed by: CRAWFORD SALLY -9.9%
4/30 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Needham & Company LLC from $52.00 to $60.00. They now have a "buy" rating on the stock. -8.1%
3/20 CDC, public health labs performed at least 44,000 COVID-19 tests [MarketWatch] -5.9%
11/7 Hologic, Inc. (HOLX) CEO Steve MacMillan on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -5.3%
10/1 Hologic CEO Steve MacMillan to Ring Nasdaq Opening Bell on October 2 -4.5%
3/10 Form 8-K HOLOGIC INC For: Mar 05 -4.5%
8/14 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus to $62.00. They now have a "buy" rating on the stock. -4.4%
3/5 German Lab Demonstrates Feasibility to Detect SARS-Coronavirus-2 (SARS-CoV-2) Using Hologic’s Panther Fusion® System -4.3%
3/21 CDC, public health labs have tested at least 54,205 Americans for coronavirus [MarketWatch] -3.7%